Anti-cancer Drugs创刊于1990年,由Lippincott Williams and Wilkins Ltd.出版商出版,收稿方向涵盖医学 - 药学全领域,此期刊水平偏中等偏靠后,在所属细分领域中专业影响力一般,过审相对较易,如果您文章质量佳,选择此期刊,发表机率较高。平均审稿速度 偏慢,4-8周 ,影响因子指数1.8,该期刊近期没有被列入国际期刊预...
《抗癌药》(Anti-cancer Drugs)是一本以医学-药学综合研究为特色的国际期刊。该刊由Lippincott Williams and Wilkins Ltd.出版商创刊于1990年,刊期Monthly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-药学领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速学术交流的信息窗...
《Anti-cancer Drugs》是一本由Lippincott Williams and Wilkins Ltd.出版的医学-药学学术刊物,主要刊载医学-药学相关领域研究成果与实践,旨在打造一种学术水平高、可读性强、具有全球影响力的学术期刊。本刊已入选SCIE来源期刊。该刊创刊于1990年,出版周期Monthly。2023
ANTI-CANCER DRUGS 期刊简介 英文简介: 抗癌药物关注的是有毒和无毒抗癌药物的临床和实验效果,特别针对癌症治疗的突破。发表的主题包括细胞毒性化疗、激素或生物反应调节剂,如白细胞介素、免疫治疗、药物设计、药物的副作用和耐药性。 中文简介:(来自Google、百度翻译) ...
Anti-Cancer Drugs的影响因子较平稳,2023-2024年度为1.8,近5年首次跌倒2.0以下,这给我们的信息是投稿的难度下降了。(实时影响因子:1.674) 3.自引率和引用次数 Anti-Cancer Drugs的自引率控制得不错,十年内一直处于2.5%以下,2023-2024年度已经下降至0%,预计下一年不会高于2%。
Anti cancer drugs Bioprocessing Building a Bioprocess for a Cancer-Fighting Biosimilar Bioprocessing Accelerating Bispecific Antibody Discovery: From Antigens to Lead Panels in Just Four Months News Uncovering Craniopharyngioma’s Growth Mechanism May Identify New Therapy...
Reports both clinical and experimental results related to anti-cancer drugs and includes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. This internationally refereed journal, devoted to the fast publication of innovative...
Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast ...
Gary: maybe as we become more specific with precision medicines high prices may be a result of our success in specifically targeting a mutation. We need to understand the targeted drugs and outcomes. Patrick: “Cancer is the last big frontier” but he says prices will come down in most case...
We all know the peril of cancer and how it can end human lives.Thanks to medical innovations and effective research for discovering new ways to fight this deadly disease. Many companies are making positive contributions in this sector. Taking the right type of drugs at the right time as per...